Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 12
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/21/2007
1.
Phase III Randomized Comparison of the Influence of Chemoprevention with Vitamin A and/or N-Acetylcysteine vs No Treatment on Development and Detection of Second Primary Cancers in Patients Curatively Treated for Laryngeal, Oral Cavity, and Nonsmall Cell Lung Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention
Closed
75 and under
EORTC-08871
EORTC-24871
Last Modified:
5/1/1998
 
First Published:
11/1/1997
2.
Phase II Chemoprevention of Head and Neck Cancer by Acetylcysteine (Summary Last Modified 05/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Prevention
Completed
Over 18
NCI
GUMC-19196
NCI-P97-0118
Last Modified:
12/18/2002
 
First Published:
7/1/1998
3.
Phase I/II Study of High-Dose Acetaminophen With Carmustine in Patients With Metastatic Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
Over 18
NCI
MSKCC-97124
NCI-H98-0014, NCT00003346
4.
Phase II Chemotherapy with Ifosfamide plus N-Acetylcysteine in Patients with Metastatic Adenocarcinoma of the Pancreas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
MAOP-5483
5.
Phase II Combination Chemotherapy with VIP (VP-16/IPP/CACP) for Refractory Hodgkin's and non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
CTEPIS-0215
NCI-T83-1118D
6.
Phase II Chemotherapy with ADR plus Cardioprotective Therapy with N-Acetylcysteine for Breast Cancer, Soft Tissue Sarcoma, and Nodular Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Closed
no age specified
NCI-78-C-152
7.
Pilot Phase II Chemotherapy with IPP plus N-Acetylcysteine for Refractory Testicular Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI-D82-067-825
8.
Phase II Chemotherapy with Ifosfamide Alone or in Combination with Other Chemotherapeutic Agents for Refractory Testicular Cancer and Extra-gonadal and Ovarian Germ Cell Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
IUMC-830226
NCI-C83-0725
9.
Phase II Chemotherapy with Ifosfamide for Advanced Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
SEG-LUN-82284
10.
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Completed
20 to 80
Other
whilde157/2003
NCT00196885
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute